Claritas Pharmaceuticals Inc V.CLAS.H

Maybe try reading the news release? Right your one of those

[Dude51]

conspearist, who can't believe anything the company says. Here's a quote read slow, try to parse the word, then repeat, "i'm a moron", here's the quote,

"By not proceeding with the acquisition of Salzman Group at this time, the company will avoid the substantial dilution that would have resulted from the issuance of additional shares to the shareholders of Salzman Group."

makes sense. So Scotty, what say you? Tell us another lie? You can do it...

[Bvukmanic]

This news was in an md&a released over 3 months ago. It doesn't mention the license fee to Salzman is $1.2 million cash (and 130 million shares). Of course the company would need to consolidate to raise capital, assuming they're able to raise capital. I doubt anyone would want to finance a pre-clinical covid therapeutic at this point when vaccines are available. Didn't Salzman

[AngelaL]

If you think this pandemic is gone in a few months, sorry to burst your bubble. Vaccines definitely aren't the whole answer. Have you been reading what's going on with mutants? The vaccines are not working against the very scary mutant Covid viruses in South Africa and Brazil, and they will surely fail against evasive new mutants that appear in the future. And vaccines aren't even 100%

[Scotty]

You're right, Covid is endemic now, it's never going away like the seasonal flu. KLY is just going to RS then dilute itself into oblivion again, all to fund another companies patent. It's just a shell company to fund privately owned research. That's beyond obvious at this point. Please don't go all in on this scam.

[Bvukmanic]

Huh? There are hundreds of vaccines and therapeutics already in development. Focused on the spike Let's start with a little background on the virus itself, the vaccines, and the variants. The coronavirus contains a "spike protein." These are literally spikes on the virus' surface that allow it to attach to cells and infect them. Vaccine makers are focused on this spike. In

[AngelaL]

You underestimate the problems in changing the vaccine to work for the new mutants. They will have to start from ground zero - new manufacturing, new clinical safety studies (even thr slightest change in the sequence can completely alter the safety profile because the new antibodies formed may cross-react with other tissues name cause toxicity), new stability questions (changing the sequence of an

[Bvukmanic]

None of that is true.

[Moonshiner592]

... and why do you say that?    

[Bvukmanic]

Are you serious? Literally everything she said was wrong. There's no evidence the two current mRNA vaccines are ineffective against the new strains. If a variant emerges that is resistant, the vaccines can easily be changed - similar to a flu shot, and they won't need additional safety studies. These vaccines only took days to actually develop after the original genome was sequenced. New

[AngelaL]

Both Pfizer and Moderna have confirmed this week that the Brazilian strain is not responsive to convalescent serum after their vaccinations. As a consequence, the U.K. government, and now other countries, has completely shut down entry of visitors from Brazil, Portugal, and South American countries bordering Brazil. The strain from Brazil has emerged in the last two weeks as the number one global

[Moonshiner592]

Vaccines can easily be changed??  These vaccines only took days to actually develop?? ... I work in vaccine research and development!  This stuff isn't true!! Gosh what an idiot windbag you are!! Do something useful for yourself  - Go back to grade school ... and DO your homework this time around FFS!! 

[Bvukmanic]

LMAO. I'd be surprised if you even graduated high school. "It took Moderna just two days to design the RNA instruction that would make cells produce the coronavirus spike protein." Google it, dumba$$.

[Bvukmanic]

Two days, dum-dum. How long do you think seasonal flu vaccines take to design? You're apparently an expert! What are you really, a plumber? 

[AngelaL]

You are confusing vaccine design with vaccine development. Design of a vaccine to address the new mutants from Brazil and South Africa is a no-brainer: it would take a college level molecular biology student no more than a coupe hours because the mutations have been published. Development of such a vaccine is an entirely different matter - it will take about one year. This is because the

[Moonshiner592]

You go girl!! 

[Bvukmanic]

Girl, she's same age as my grandma.

[Bvukmanic]

That would only be the case if there were significant mutations, and right now it is not mutating rapidly. B1.1.7 strain only has 8 amino acid mutations, of 1273.

[Scotty]

Right, so you didn't read the release did you? Can you read? Maybe you should ask Bob to send you an audio recording of it. Beyond that, how do you think this company will raise money moving forward? Waves upon waves of dilution, to keep the lights on and fund another companies patent. Even after a 20:1 this company will be back to pennies in a few years, if they can manage to sucker some more

[Captainblk]

it really does feel like this company's business model is to bank roll the research for other random a$$ companies that come along, all on shareholder dollars.

[Bvukmanic]

Completely agree, except the companies aren't random.

[Dude51]

Beam me up Scotty, your losing it, give us a link to an actual fact that is not on a fox news site, loser.

[Scotty]

Damn, you're really deep into the Kalyteran cult aren't you? What do they do to you people over there? Scary!